Skip to main content

Table 3 Concomitant medication

From: Characteristics and health related quality of life in a population with advanced chronic obstructive pulmonary disease, a cross-sectional study

Pharmacological variables (n = 242)

n (%)

Regularly orally administered medication

 Weak analgesics and nonsteroidal anti-inflammatory agents (NSAID)

82 (33.9)

 Opioids on indication pain

29 (12.0)

 Opioids on indication dyspnea

13 (5.4)

 Benzodiazepines

16 (6.6)

 Antidepressants

32 (13.2)

 Antipsychotics

10 (4.1)

 Cannabis oil

1 (0.4)

Regularly inhaled medication

 Short acting bronchodilaters

219 (90.5)

 LAMAa

3 (1.2)

 LABAb

3 (1.2)

 ICSc

1 (0.4)

 LAMA + LABA

85 (35.1)

 ICS + LABA

8 (3.3)

 ICS + LAMA

2 (0.8)

 ICS + LABA + LAMA

138 (57.0)

  1. aLAMA long-acting muscarinic antagonist; bLABA long-acting β2-agonist; cICS, inhaled corticosteroid